Lilly(LLY) ZACKS·2024-10-30 12:56Group 1: Earnings Performance - Eli Lilly reported quarterly earnings of 1.52 per share, representing an earnings surprise of -22.37% [1] - The company posted revenues of 9.5 billion [2] - Over the last four quarters, Eli Lilly has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Group 2: Stock Performance and Outlook - Eli Lilly shares have increased approximately 55% since the beginning of the year, outperforming the S&P 500's gain of 22.3% [3] - The sustainability of the stock's immediate price movement will depend on management's commentary on the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the coming quarter is 14.15 billion, and for the current fiscal year, it is 46.25 billion [7] Group 3: Industry Context - The Large Cap Pharmaceuticals industry, to which Eli Lilly belongs, is currently in the top 23% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]